Transcription factor complex formation and chromatin fine structure alterations at the murine c-fms (CSF-1 receptor) locus during maturation of myeloid precursor cells by Tagoh, Hiromi et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Transcription factor complex formation and chromatin fine
structure alterations at the murine c-fms (CSF-1 receptor) locus
during maturation of myeloid precursor cells
Citation for published version:
Tagoh, H, Himes, R, Clarke, D, Leenen, PJM, Riggs, AD, Hume, D & Bonifer, C 2002, 'Transcription factor
complex formation and chromatin fine structure alterations at the murine c-fms (CSF-1 receptor) locus
during maturation of myeloid precursor cells' Genes & Development, vol 16, no. 13, pp. 1721-37.,
10.1101/gad.222002
Digital Object Identifier (DOI):
10.1101/gad.222002
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher final version (usually the publisher pdf)
Published In:
Genes & Development
Publisher Rights Statement:
© 2002 by Cold Spring Harbor Laboratory Press ISSN 0890-9369/02 $5.00; www.genesdev.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 20. Feb. 2015
 10.1101/gad.222002Access the most recent version at doi:
 2002 16: 1721-1737 Genes Dev.
  
Hiromi Tagoh, Roy Himes, Deborah Clarke, et al. 
  
maturation of myeloid precursor cells
alterations at the murine c-fms (CSF-1 receptor) locus during 
Transcription factor complex formation and chromatin fine structure
  
References
  
 http://genesdev.cshlp.org/content/16/13/1721.full.html#ref-list-1
This article cites 56 articles, 31 of which can be accessed free at:
Service
Email Alerting
 click here.right corner of the article or
Receive free email alerts when new articles cite this article - sign up in the box at the top
 http://genesdev.cshlp.org/subscriptions
go to: Genes & Development To subscribe to 
Cold Spring Harbor Laboratory Press
 Cold Spring Harbor Laboratory Press on July 30, 2013 - Published by genesdev.cshlp.orgDownloaded from 
Transcription factor complex formation
and chromatin fine structure alterations
at the murine c-fms (CSF-1 receptor)
locus during maturation of myeloid
precursor cells
Hiromi Tagoh,1 Roy Himes,2 Deborah Clarke,1 Pieter J.M. Leenen,3 Arthur D. Riggs,4
David Hume,2 and Constanze Bonifer1,5
1Molecular Medicine Unit, University of Leeds, St. James’s University Hospital, Leeds LS9 7TF, UK; 2Institute for Molecular
Biosciences and ARC Special Research Centre for Functional and Applied Genomics, University of Queensland Q4072,
Brisbane, Australia; 3Deptartment of Immunology, Erasmus MC, University Medical Center, 3000 DR Rotterdam,
The Netherlands; 4Department of Biology, Beckman Institute of City of Hope, Duarte, California 91010, USA
Expression of the gene for the macrophage colony stimulating factor receptor (CSF-1R), c-fms, has been viewed
as a hallmark of the commitment of multipotent precursor cells to macrophages. Lineage-restricted expression
of the gene is controlled by conserved elements in the proximal promoter and within the first intron. To
investigate the developmental regulation of c-fms at the level of chromatin structure, we developed an in vitro
system to examine the maturation of multipotent myeloid precursor cells into mature macrophages. The
dynamics of chromatin fine structure alterations and transcription factor occupancy at the c-fms promoter and
intronic enhancer was examined by in vivo DMS and UV-footprinting. We show that the c-fms gene is already
transcribed at low levels in early myeloid precursors on which no CSF-1R surface expression can be detected.
At this stage of myelopoiesis, the formation of transcription factor complexes on the promoter was complete.
By contrast, occupancy of the enhancer was acutely regulated during macrophage differentiation. Our data
show that cell-intrinsic differentiation decisions at the c-fms locus precede the appearance of c-fms on the cell
surface. They also suggest that complex lineage-specific enhancers such as the c-fms intronic enhancer
regulate local chromatin structure through the coordinated assembly and disassembly of distinct transcription
factor complexes.
[Key Words: CSF-1 receptor; chromatin; in vivo footprinting; myeloid progenitor cells; macrophage
differentiation]
Received December 5, 2001; revised version accepted May 8, 2002.
The decision for a multi- or pluripotent progenitor cell to
develop into a single lineage involves the assembly of
key regulatory genes into transcriptionally active chro-
matin structures, and coordinate inactivation of genes
involved in alternative cellular fates. An understanding
of the process of chromatin assembly and remodeling
must therefore underlie any comprehensive model of
cell lineage commitment. The hematopoietic system
has great advantages as a general model for study of
the epigenetic basis of developmental processes, because
differentiation can, to a significant extent, be recapitu-
lated in cell culture. Hematopoietic cells arise from plu-
ripotent stem cells of the bone marrow and develop via
different types of precursor cells, which become pro-
gressively committed to the different branches of the
blood cell system. As a model for cell fate decisions
within the hematopoietic system, macrophage develop-
ment represents a particularly interesting differentiation
pathway.
Mononuclear phagocytes are a family of cells compris-
ing bone marrow progenitors, blood monocytes, and tis-
sue macrophages (for review, see Gordon et al. 1992).
Despite their extensive heterogeneity, expression of the
c-fms (Macrophage-Colony-Stimulating-factor [CSF-1]
receptor) gene is common to all macrophages. CSF-1 is
required for macrophage survival in vitro and in vivo
(Roth and Stanley 1992; Dai et al. 2002). C-fms mRNA is
expressed constitutively in placental trophoblasts and
mononuclear phagocytes. It is detectable in the earliest
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yolk-sac phagocytes formed during mouse development
and expression is maintained in all macrophages
throughout adult life (Lichanska et al. 1999). Transcrip-
tion of c-fms in human trophoblasts and macrophages
initiates from two different promoters separated by a 25-
kb intron. Exon 1 is transcribed only in trophoblasts,
whereas exon 2 is the first exon of transcripts made in
macrophages (Visvader and Verma 1989; Roberts et al.
1992). In mice, the promoter architecture is different,
and trophoblast transcription initiation occurs at several
sites within 1 kb upstream of the macrophage initiation
site, generating multiple alternatively-spliced noncoding
exons (R.T. Sasmono, D. Oceandy, J.W. Pollard, W. Tong,
P. Low, R. Thomas, P. Pauli, M.C. Ostrouski, S.R.
Himes, and D.A. Hume, in prep.). Despite the distinc-
tion, it remains appropriate to call the first coding exon,
exon 2 in both species.
Transcription of the mouse fms gene in macrophages
has been studied in some detail. The proximal promoter
contains multiple purine-rich elements that bind the
macrophage-restricted transcription factor PU.1 and
other members of the Ets transcription factor family
(Ross et al. 1998; Rehli et al. 1999). We have shown re-
cently that a highly conserved element of the first down-
stream intron of the gene, referred to as the Fms intronic
regulatory element (FIRE) cooperates with the proximal
promoter to generate appropriate expression of the gene
in stably transfected cells (Himes et al. 2001) and in
transgenic mice (R.T. Sasmono, D. Oceandy, J.W. Pol-
lard, W. Tong, P. Low, R. Thomas, P. Pauli, M.C. Os-
trouski, S.R. Himes, and D.A. Hume, in prep.). Because
CSF-1 is an important growth factor for macrophages in
vivo, the activation of the c-fms gene locus has been
viewed as a key event in the commitment of multipotent
precursor cells to a macrophage-restricted differentiation
phenotype. However, committed macrophage progenitor
cells that lack CSF-1 receptor on their surface have been
described in mouse bone marrow (Sudo et al. 1995), in-
dicating that cell intrinsic differentiation decisions oc-
cur prior to the appearance of c-fms on the cell surface.
Only recently has the regulation of cell fate decisions
at the epigenetic level been examined. Experiments from
several laboratories including our own demonstrated
that lineage-restricted genes in immature precursors
could exist in a potentiated chromatin state (Bossard and
Zaret 1998; Kramer et al. 1998; Kontaraki et al. 2000).
The existence of this state may underlie the observations
that precursor cells can exhibit promiscuous expression
of lineage specific markers and regulator genes (Hu et al.
1997; Enver and Greaves 1998; Nutt et al. 1999). Early
chromatin reorganization probably sets the stage for the
formation of stable transcription factor complexes at
later developmental stages that drive transcription. Once
assembled, transcription factor complexes on individual
cis-regulatory elements can consist of different sets of
transcription factors, depending on the developmental
state (Gualdi et al. 1996; Roque et al. 1996; Bossard and
Zaret 1998). Within the hematopoietic system, a few ex-
periments have correlated transcription factor occu-
pancy at specific genes with a fixed differentiation state
of primary cells (Shaffer et al. 1997; Hernandez-Munain
et al. 1998, 1999), but none has described the dynamics
of transcription factor assembly and chromatin fine
structure alterations at a given gene throughout ex-
tended stages of cell differentiation.
In this report we describe the assembly of stable tran-
scription factor complexes on c-fms cis-regulatory ele-
ments (promoter and FIRE) during the differentiation of
primary early myeloid precursor cells into activated
macrophages in vitro using in vivo DMS and UV-photo-
footprinting. We show that the c-fms gene is already
transcribed in early myeloid precursors that lack detect-
able CSF-1 receptor on their surface and that low level
transcription is associated with complete transcription
factor complex assembly on the c-fms promoter. Subse-
quently complex alterations in transcription factor occu-
pancy accompany terminal differentiation and activa-
tion. Our data suggest that CSF-1 acts on cells in which
the c-fms gene has been already assembled into active
chromatin. CSF-1 stimulates the growth of these cells,
which further modulate their chromatin state to direct
terminal differentiation.
Results
Extended regions of chromatin around the c-fms
proximal promoter and intronic enhancer
become accessible specifically in macrophages
To obtain insight into the regulation of the murine c-fms
locus at the level of chromatin structure, we have pre-
viously mapped the position of macrophage-specific
DNaseI hypersensitive chromatin sites (DHSs) over a
15-kb region upstream and downstream of the c-fms
proximal promoter (Himes et al. 2001; Fig. 1A). We de-
tected three macrophage specific regions of DNaseI hy-
persensitivity, all of which coincide with DNA se-
quences that are highly conserved between mouse and
man. Two DHS were present in the second intron, one
very strong site is an enhancer that is absolutely required
to activate c-fms reporter constructs stably integrated
into chromatin (Himes et al. 2001; R.T. Sasmono, D.
Oceandy, J.W. Pollard, W. Tong, P. Low, R. Thomas, P.
Pauli, M.C. Ostrouski, S.R. Himes, and D.A. Hume, in
prep.). This element, the FIRE, is a 300-bp region that is
more highly conserved between mouse and human that
the c-fms coding sequence. To complement and extend
these experiments, we determined chromatin accessibil-
ity at the proximal promoter (Fig. 1B) and downstream
sequences (Fig. 1A) by partial digestion with different
restriction enzymes in fibroblasts and macrophages that
lack or express c-fms mRNA, respectively. The data re-
vealed extended regions of chromatin that become acces-
sible to restriction enzyme digestion in macrophages,
400-bp of chromatin flanking the promoter and >2 kb
around the downstream DHSs. This may reflect the fact
that the c-fms proximal promoter is a GC-rich TATA-
less promoter with a large number of scattered transcrip-
tional start sites. The DNA in the first intron represents
DNA that is actively transcribed and thus is accessible
Tagoh et al.
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to RNA-PolII action. Interestingly, some restriction sites
were also weakly accessible in fibroblasts, which may
represent sites localized in nucleosomal linker regions.
Taken together, our data extend the earlier evidence
(Himes et al. 2001) of extensive chromatin remodeling
events at the c-fms locus in macrophages.
The establishment of a differentiation system
for macrophages from purified mouse bone marrow
precursor cells suitable for chromatin fine
structure studies
Although chromatin studies at the resolution of South-
ern blotting can give detailed insight into the position of
cell-type and cell-stage specific cis-regulatory elements,
they are neither sufficiently sensitive nor of high enough
resolution to explain the molecular details of transcrip-
tion factor occupancy and chromatin fine structure
changes during cell differentiation. We therefore set out
to establish a purification strategy for defined macro-
phage precursors that could be differentiated in vitro and
that would produce sufficient cell numbers for PCR-
based chromatin structure analysis methods. Progenitor
cells with high proliferative potential require combined
treatment with CSF-1 and other factors, such as Inter-
leukins 3 (IL-3) and 1 (IL-1), to undergo rapid expansion
(Bartelmez et al. 1989; Breen et al. 1990).
We aimed at isolating sufficient numbers of the earli-
est cells with myeloid characteristics that were able to
respond to growth stimulation by IL-3 and CSF-1. In the
scheme outlined in Figure 2A, these cells resemble com-
mon myeloid precursors (CMPs). Figure 2B describes the
purification strategy in which we first remove all mature
cells by depletion of lineage marker positive cells using
magnetic beads. In the antibody cocktail we included
several macrophage specific markers (Mac1 and F/480)
and used CD19 to remove B-cells, as early macrophage
precursors may be B220 positive (Slieker et al. 1993). The
resulting lineage negative cells were stained with c-kit,
ER-MP12 and ER-MP20 antibodies. c-kit antibodies
recognize all hematopoietic stem cells, ER-MP12 is a
marker for morphologically undifferentiated myeloid
blast cells, whereas ER-MP20 recognizes committed
macrophage precursors (late CFU-M) and monocytes
(DeBruijn et al. 1994). We purified blast cells in the ER-
MP12hi/c-kithi/ER-MP20− fraction as well as remaining
Figure 1. Chromatin structure of mouse c-fms locus regulatory regions around the proximal promoter. (A) DNaseI hypersensitive
sites (DHSs) represented as black arrows and restriction enzyme accessible sites (ovals) downstream of the PstI site at +310 (relative
to the ATG). Southern blot analysis was performed on PstI-digested genomic DNA prepared from fibroblasts and macrophages that
were treated with 50U and 100U of XbaI, HinfI, PvuII, SspI, and XmnI. A PvuII (+496)–BamHI (+850) probe was used as indicated
(hatched box). (B) Restriction enzyme accessible sites upstream of the BamHI site (+849). One hundred units of restriction enzymes
(HinfI, BanII, HindIII, and EcoRI) were used and BamHI was used for complete digestion of genomic DNA for Southern blot analysis.
The blot was probed with the PvuII (+496) to BamHI (+849) fragment (hatched box). Bands resulting from cleavage are indicated by open
(weak accessibility) and closed (high accessibility) ovals. Black boxes show the second and third exons.
Factor assembly on c-fms gene during myelopoiesis
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ER-MP20−/c-kithi cells that express no or only low levels
of ER-MP12. Colony forming ability was assessed in a
mixed colony assay that contained myeloid growth fac-
tors, stem cell factor and EPO (Fig. 2C). Both cell popu-
lations contained precursor cells; however, the highest
proportion of clonogenic precursors was present in the
ER-MP12hi/c-kithi population. Neither population con-
tained any IL-7 dependent B-cell precursors, but both
were able to form all myeloid cell types (granulocytes,
monocytes/macrophages, mast cells and erythrocytes;
Fig. 2D, lower panel). From the colony assay it seemed
that the ER-MP12−/c-kithi population was less pure, but
contained a higher proportion of more primitive precur-
sor population (CFU-mix) as compared to the ER-
MP12hi/c-kithi/ER-MP20− population (Fig. 2D), whereas
CFU–GM colony forming ability was similar. This is
consistent with the finding that hematopoietic stem
cells express low levels of ER-MP12 (van der Loo et al.
1995).
We next subjected our purified precursor populations
to in vitro macrophage differentiation conditions in a
medium containing IL-1, IL-3, and CSF-1 as described in
Jägle et al. (1997). Cell morphology and surface marker
expression of differentiating cells are depicted in Figure
3. ER-MP12hi/c-kithi/ER-MP20− cells did not express lin-
eage markers (Fig. 3D) and displayed a homogenous blast
like morphology (Fig. 3F) with a characteristic forward
scatter/sideward scatter (FSC/SCC) profile (Fig. 3A). Dur-
ing differentiation this profile progressively shifted
towards the heterogeneous pattern seen with mature
monocytes/macrophages (Fig. 3A).
Only the ER-MP12hi/c-kithi/ER-MP20−population
(Fig. 3F) was capable of immediately responding to our
growth factor conditions. The first dividing blast cells
were seen as early as day 1 with only a limited amount of
apoptosis being apparent in the cultures (∼30% of the
cells), and after day 2 the culture only contained rapidly
growing nonadherent myeloid blasts cells (Fig. 3F). The
cells rapidly lost the c-kit staining that was initially
present during precursor purification (Fig. 3C). After day
4 the first adherent monocytes were apparent (Fig. 3F).
By day 7 pure adherent monocyte/macrophage cultures
were formed (Fig. 3F) that could be further stimulated by
the addition of LPS and -Interferon. During macrophage
differentiation, expression of ER-MP12 in the entire cell
population decreased and ER-MP20 expression increased
as expected (DeBruijn et al. 1994), whereby mature mac-
rophages did not express either marker (Fig. 3B).
The different types of hematopoietic precursors can
not only be characterized by their surface marker expres-
sion, but also by the expression of transcription factors
and marker genes specific for a defined differentiation
state (Akashi et al. 2000). We therefore conducted an
extensive RT–PCR experiment examining the expres-
sion levels of a number of such genes in both purified
precursor populations (Fig. 4, ER-MP12−/c-kithi, ER-
MP12hi/c-kithi) and the cells from different time points
during the in vitro differentiation culture. Both precursor
populations expressed mRNA encoding c-myb, GATA-1,
GATA-2, and myeloid-associated factors such as PU.1,
AML1, C/EBP, and C/EBP (Tenen et al. 1997). The
expression of both C/EBP and C/EBP mRNA was up-
regulated during the early stages of macrophage differen-
tiation, whereas c-myb, GATA-1, GATA-2, were down-
regulated. AML1 and PU.1 mRNA levels declined
slightly in mature macrophages. Mouse lysozyme is
highly expressed in macrophages and granulocytes and is
switched on at the CFU-GM stage (Jägle et al. 1997). No
expression of this gene was detected in purified precur-
sors and it was first detected at a low level at day 2,
confirming that we have indeed purified multipotent
myeloid progenitor cells. The inducible nitric oxide syn-
thase (iNOS) gene, a marker for mature, activated mac-
rophages (Alley et al. 1995) was not expressed in any of
the precursor populations. As expected, expression of
iNOS required treatment of the cells with LPS/-Inter-
feron.
The comparison of their colony forming ability, cell
surface marker, and marker gene expression characteris-
tics with what was described previously for the common
myeloid progenitor cell (Akashi et al. 2000; Fig. 2A) in-
dicates that the ER-MP12hi/c-kithi/ER-MP20− popula-
tion represents a similar multipotent myeloid precursor
population. This cell population, which we are using as
a starting population for our in vivo footprinting assays
(1) has no B-lymphoid potential, (2) represents an earlier
myeloid differentiation stage than CFU-GM, and (3)
within the limits of our assay system, is not contami-
nated with mature cells.
ER-MP12hi/c-kithi/ER-MP20− cells do not display
measurable CSF-1 receptor protein on their surface
but express low levels of c-fms mRNA
The expression of c-fms in the macrophage differentia-
tion system was assessed by flow cytometry using an
anti-c-fms antibody (Sudo et al. 1995; Fig. 3E). No cells
expressing the surface receptor could be detected in the
initial purified ER-MP12hi/c-kithi/ER-MP20− (day 0). Af-
ter day 2 of in vitro differentiation, CSF-1 receptor was
detected at a low level on most cells. The cell population
homogeneously shifted to higher expression levels at day
3 and reached a plateau at day 4. In late monocytes and
adherent macrophages, the level of CSF-1 receptor pro-
tein started to decrease. The up- and down-regulation of
CSF-1 receptor expression was consistent with the
mRNA levels in the population (Fig. 4, upper left panel).
With the more sensitive RT–PCR, a low level of c-fms
mRNA was detectable in both populations of purified
precursors at day 0. C-fms messenger RNA levels in dif-
ferentiating cells increased with time reaching their
highest levels in day 7 monocytes/macrophages. Treat-
ment of these cells with LPS and LPS/-Interferon that
was sufficient to induce iNOS expression, down-regu-
lated c-fms mRNA levels, as it was shown previously by
nuclear run-on assays (Gusella et al. 1990) and studies of
mRNA elongation (Yue et al. 1993).
Taken together, our experiments show that differenti-
ating cells undergo a defined order of morphological,
gene expression, and surfacemarker expression alterations.
Factor assembly on c-fms gene during myelopoiesis
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The c-fms promoter is occupied in c-fms low-expressing
precursor cells and maintains the same chromatin fine
structure throughout macrophage differentiation
The experiments described above demonstrated that in
our in vitro macrophage differentiation system the c-fms
gene is synchronously activated in a cell population of
sufficient size for chromatin assembly studies. We there-
fore set out to examine changes in transcription factor
occupancy on c-fms cis-regulatory elements during mac-
rophage in vitro differentiation. To obtain this informa-
tion we used the in vivo footprint methods described by
Kontaraki et al. (2000), which depend on the fact that
transcription factors and chromatin structure affects the
reactivity of DNA with dimethyl sulfate (DMS) or UV,
both of which can be applied to intact cells. After in vivo
formation of alkylated or dimerized bases, the position of
these lesions is determined at nucleotide resolution by
use of LM-PCR or a related technique (TD-PCR; see
Chen et al. 2001).
Figure 4. Marker gene and transcription factor gene expression. RT–PCR was performed on the total RNA prepared from purified
precursor and differentiated cells as described in Materials and Methods. Arbitrary units were calculated after determining the
fluorescent intensity of DNA stained with ethidium bromide using the Molecular Imager FX system. The bars represent the mean
value of two independent amplifications normalized to GAPDH intensity.
Factor assembly on c-fms gene during myelopoiesis
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The pattern of reactivity with DMS for several cell
types and enriched fractions is shown in Figure 5A. This
type of data was used to determine the in vivo transcrip-
tion factor occupancy of the c-fms proximal promoter,
and the results are summarized in Figure 5B,D. Three
purine-rich ets binding sites and a C/EBP site described
previously (Yue et al. 1993; Reddy et al. 1994; Ross et al.
1998; Xie et al. 2002) were found to be occupied in vivo,
as evidenced by changed reactivity to DMS relative to
naked DNA and control cells.
Two results are noteworthy. At day 0 in ER-MP12hi/
c-kithi/ER-MP20− cells, there was apparent complete oc-
cupancy of the PU.1 sites at −103 bp, −130 bp, and −173
bp (relative to the ATG) as well as DMS-hyperreactivity
Figure 5. In vivo genomic footprinting of the c-fms promoter by LM–PCR and TD–PCR. (A) In vivo transcription factor occupancy
of the mouse c-fms promoter region in purified precursor and in vitro differentiated cells by DMS footprinting. From left to right:
DMS-treated naked DNA (G); embryonic fibroblast (EF); bone marrow cell fractions Lin−/c-kit+/ERMP12− (ckit+MP12−) and Lin−/
c-kit+/ERMP12+ (d0); and in vitro differentiated cells (d2, d4, d7, d7+LPS). Primer set Prom01–03 was used to analyze upper strand of
c-fms promoter region (Materials and Methods). Hyperreactive G(N7) contacts are indicated by closed circles on the right of each lane
and protected Gs are indicated by open circles. The different transcription start sites are indicated by arrows on the left. The number
on the right indicates the nucleotide position relative to the ATG, according to the published sequence. Protein binding sites are
indicated on the right as a line. (B) Quantified and normalized band intensity of the DMS methylated Gs of the PU.1 binding site in
the promoter. The LM-PCR products were labeled as described (Kontaraki et al. 2000) with IRD700 fluorescent dye-labeled primer and
a LICOR DNA sequencer used to separate the fragments and provide quantitative, digitized data. To compensate the variation of
sample loading, the band intensity on each lane was normalized by total lane intensity. Each bar shows the band intensity of Gs at
the PU.1 binding site. (C) UV-photofootprinting analysis of the c-fms promoter. Naked DNA (DNA) or living cells (EF, ckit+MP12−,
d0, d2, d3, d4, d7, d7+LPS) were irradiated with UV, and UV dimer formation was detected by TD–PCR (Kontaraki et al. 2000). The
primer set used was the same as used for LM–PCR in A. (M) Size marker. Open circles on the right of each lane indicate diminished
UV dimer formation compared with naked DNA. Gray circles mark chromatin fine structure changes specific for LPS treated
macrophages (D) Summary of transcription factor binding sites occupied in vivo. Transcription factor binding sites and G(N7) contacts
are indicated and transcription start sites are shown as arrows. The numbers are nucleotide position relative to the ATG.
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of the C/EBP site at −161 bp. To perform accurate quan-
tification and normalization of the bands, samples were
labeled with fluorescent primers and were analyzed and
quantified on a LiCOR sequencer as described in Kon-
taraki et al. (2000). This analysis confirmed high occu-
pancy of the c-fms proximal promoter region in myeloid
precursors. An example for such an analysis examining
the −130 bp PU.1 site is depicted in Figure 5B. Weak
DMS hyper-reactivity at the −130 bp PU.1 site was also
detected in the ckit+/ER-MP12− precursor population,
indicating that the low level of expression in this popu-
lation may originate from a few contaminating c-fms
expressing cells. It is also apparent that ongoing tran-
scription starting from the clustered transcription start
sites downstream of the PU.1 site at−130 bp correlates
with a significant change in DMS accessibility at a num-
ber of G-residues in this area, but the accessibility is not
affected by the level of transcription.
DMS in vivo footprinting gives valuable information
about the binding of transcription factors in living cells,
but relatively little information about chromatin struc-
ture, as nucleosomes do not affect DMS reactivity. We
recently developed a novel highly sensitive UV-photo-
footprinting technique that detects changes in DNA fine
structure generated by DNA-protein interaction (Ko-
mura and Riggs 1998; Chen et al. 2001) and is based on
the differential formation of UV-dimers. We applied this
technique to the cell populations described above. The
result is depicted in Figure 5C. As with DMS in vivo
footprinting, a number of chromatin fine structure dif-
ferences downstream of the −103 PU.1 site were detect-
able in c-fms-expressing cells when compared to fibro-
blasts and ER-MP12−/c-kithi/ER-MP20− cells. Interest-
ingly, although transcription factor occupancy was
different, the chromatin structure around the PU.1/C/
EBP binding site at −176 bp, which is upstream of the
area where mRNA initiation occurs, was highly similar
between ER-MP12−/c-kithi/ER-MP20− cells and ER-
MP12hi/c-kithi/ER-MP20− cells, but differed from that of
fibroblasts. The UV-dimer pattern of the latter re-
sembled what was obtained with naked DNA. Changes
caused by LPS treatment are also apparent and will be
discussed in a later section.
Transcription factors binding to FIRE
As noted above, FIRE plays a crucial role in the regula-
tion of c-fms expression. FIRE contains numerous can-
didate elements within a remarkably conserved 300-bp
region comprising an almost continuous array of appar-
ent consensus elements that might bind myeloid-spe-
cific factors such as PU.1/ets, C/EBP, and AML1 (Himes
et al. 2001; Fig. 6C). However, whether these proteins
actually bind to these sites had not been examined pre-
viously. We determined transcription factor occupancy
of FIRE by in vivo DMS-footprinting in the cell popula-
tions described above. The results are depicted in Figure
6. The 5 part of FIRE is characterized by two SP1/3 sites
that both extensively overlap with PU.1/ets consensus
sequences (promoter proximal and distal SP1/3/ets clus-
ters). Both clusters were occupied in day 7 macrophages.
Our in vivo footprinting experiments in addition provide
evidence for occupancy of at least one of two AML1 sites
(AML1[2]) in the FIRE element. Whether AML1 site 1
(Fig. 6C) was occupied by AML1 in vivo was difficult to
decide, due to an extensive overlap with ets and SP1/3
consensus sequences that both share the same potential
G(N7) contacts. Further downstream, two PU.1 sites
that partially overlap were occupied in vivo. 3 of these
an ets binding site and a C/EBP site were occupied, as
well as binding sites for a number of unknown factors.
One of these unknown factors (FBF1, see below) bound at
the 3 end of FIRE with a footprint over the sequence
ggggggtttga. No matrix for known transcription factor
binding to this site could be identified.
To validate the footprinting data and to confirm that
macrophages express nuclear proteins that bind these el-
ements, electrophoretic mobility shift assays (EMSA)
were performed with nuclear extract from bone marrow
derived macrophages (BMM) (Fig. 8, see below). Protein
binding from MOP31C B lymphoblasts were also ana-
lyzed to perform an initial evaluation whether any com-
plexes displayed myeloid specificity. An Sp1 protein
complex was observed on an oligonucleotide containing
the distal Sp1 consensus element of FIRE, as determined
by supershift assay with Sp1 specific antibody (Fig. 8A).
A more extended oligo was also recognized by a factor
binding to the ets site (data not shown). Similar Sp1 bind-
ing/antibody supershift and ets binding was observed on
an oligonucleotide which contained the identical proxi-
mal FIRE Sp1 element (data not shown). The novel ele-
ment within FIRE bound a factor with myeloid specific-
ity as it showed no detectable protein binding in the
lymphocyte cell lines (Fig. 8B). We refer to this complex
as FBF1 (FIRE-binding-factor 1). EMSAs examining bind-
ing of the ubiquitously expressed oct1 factor demon-
strated a comparable quality of the extracts (Fig. 8B,
lower panel).
Both AML1 sites in FIRE showed binding of multiple
protein complexes of identical mobility to those binding
the previously characterized AML1 binding site within
the Molony murine leukemia virus enhancer (MMLV)
(Wang and Speck 1992; Fig. 8C,D; data not shown). There
is no sequence homology outside of the core consensus
TGTGGT present in the FIRE and MMLV sites. All pro-
tein complexes appeared to be related to the AML/CBF
core binding factor proteins because the FIRE AML site
and the MMLV AML site could cross-compete for pro-
tein binding.
Dynamic alterations in transcription factor occupancy
at FIRE during myeloid precursor maturation
In contrast to the promoter, the assembly of the different
transcription factor complexes at FIRE was differentially
regulated. The factor binding sites at FIRE appeared to be
only partly occupied in day 0 myeloid precursor cells
(Fig. 6). In addition, a number of individual binding sites
such as the proximal SP1 and ets sites, the AP2 and the
FBF1 site were bound in ER-MP12−/c-kithi/ER-MP20−
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Figure 6. In vivo transcription factor occupancy of FIRE in purified precursor and differentiated cells. DMS in vivo footprinting
analyses for upper strand (A) and lower strand (B) of FIRE were performed on purified precursors and differentiated cells as described
in Fig. 5A. Primer sets GB04–06 and GB01–03 were used to analyze upper and lower strands. For all other symbols see legend of Fig.
5. Only alterations in band intensity of at least twofold were considered to be significant as determined by the quantification of
LM-PCR products run on a LICOR sequencer as depicted in Fig. 7. (C) Summary of the transcription factor assembly on the FIRE.
Transcription factor binding sites are indicated as boxes, and thick bars between upper and lower strands represent the nucleotide
positions that are conserved between mouse and human.
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cells, whereas other binding sites such as the distal SP1
site were not occupied. During myeloid precursor matu-
ration, the factor complexes on a subset of binding sites
such as the PU.1 (2), C/EBP, AP2, ets, FBF1 sites, some
unknown factors and the proximal SP1/ets cluster were
coordinately assembled and disassembled. An initial up-
regulation was followed by a down-regulation at day 7.
This result was highly reproducible and could be con-
firmed by the quantification of normalized bands (Fig. 7).
Interestingly, not all factor-binding sites were bound with
the same kinetics. The quantification of bands also re-
vealed that the proximal SP1/ets cluster (Fig. 7C), the PU.1
(1) site at +2781 (Fig. 7B), and the distal SP1 cluster at +2718
(data not shown) stay occupied in day 7 macrophages.
Distinct changes in transcription factor occupancy
and chromatin fine structure at c-fms cis-regulatory
elements after LPS stimulation
To examine further the relationship between chromatin
fine structure/site occupancy and c-fms transcription we
examined the effect of LPS on macrophages differenti-
ated from purified precursors. LPS treated macrophages
cease to grow and undergo a number of functional and
morphological changes (for review, see Sweet and Hume
1996). LPS promotes macrophage activation and causes
down-regulation of c-fms expression at the transcrip-
tional level (Gusella et al. 1990; Yue et al. 1993).
In the promoter, the down-regulation of c-fms expres-
sion after LPS treatment is associated with a reduction in
occupancy for all promoter-bound transcription factors
as exemplified by a weaker DMS hyper-reactivity at the
PU.1 site at −130 bp (Fig. 5B, top panel). This result was
confirmed by UV-photofootprinting. DNA prepared from
LPS treated cells showed a number of quantitative and
qualitative changes in UV-dimer formation frequency as
compared to untreated cells and precursors (indicated as
gray circles in Fig. 5C). The effect of LPS was complex.
Chromatin structure around the transcriptional start
sites seemed to revert to the inactive pattern seen in
fibroblasts but in other regions it was unchanged (up-
stream of −161 bp, see above) or a new pattern was ob-
served that differed from that observed with fibroblasts
(downstream of −57 bp).
At FIRE, LPS treatment led to a further reduction in
binding of the factors already reduced in binding at day 7
of differentiation (Figs. 6, 7, top panel). In contrast to the
promoter and as noticed above, also after LPS stimula-
tion a subset of sites, the PU.1 (1) site and the distal SP1
cluster, stayed completely occupied. We observed no fur-
ther changes in transcription factor composition of the
FIRE enhancer complex.
Discussion
Multipotent progenitor cells display no measurable
CSF-1 receptor on the surface but express a low level
of c-fms mRNA
One goal of this study was to establish an in vitro differ-
entiation system for macrophages, and then use it to
study the dynamics of transcription factor assembly and
chromatin fine structure alterations on genes specifi-
cally expressed by macrophages. We succeeded in puri-
fying a homogeneous population of early multipotent
myeloid precursor cells. This was indicated by the com-
bination of growth factor responsiveness, surface marker
expression, colony forming ability, and gene expression
profile of our purified cell populations. We detected low
levels of c-fms mRNA in the purified progenitors. Al-
though we were unable to detect any CSF-1 receptor pro-
tein expression on the surface of these cells, this may
mean that some cells express a low level of functional
receptor protein that would render them CSF-1 respon-
sive. A number of studies have detected c-fms expression
in multipotent hematopoietic precursor cells (Hu et al.
1997; Nutt et al. 1999; Akashi et al. 2000) and even pu-
rified hematopoietic stem cells (HSCs) (Kondo et al.
2000). This is in contrast to other genes, such as the
chicken lysozyme gene that bind transcription factors
and activate transcription exclusively in more mature
myeloid cells (Kontaraki et al. 2000; J. Kontaraki, S.
Chong, A.D. Riggs, and C. Bonifer, unpubl.). It is likely
that c-fms mRNA is actually expressed in only a subset
of these cells at any moment in time, as shown by stud-
ies that examined c-fms expression in purified lin-/
CD34+ precursors at single cell level (Hu et al. 1997), but
this is not a key issue. The key point is that prior to
lineage commitment and high level expression of c-fms,
we can demonstrate complete transcription factor occu-
pancy of the c-fms promoter and reorganization of chro-
matin in the precursor population as a whole. Our ex-
periments add to the growing number of results indicat-
ing that epigenetic cell fate decisions precede the
appearance of surface marker proteins and morphologi-
cal changes (Bossard and Zaret 1998; Hernadez-Munain
et al. 1999; Kontaraki et al. 2000; Spicuglia et al. 2000).
For the c-fms gene, we now know which factors are in-
volved in these decisions. From the viewpoint of the bi-
ology of CSF-1, the data are consistent with the view
that this macrophage growth factor acts to promote
growth and survival of hematopoietic cells that are al-
ready committed to myelopoiesis (Lagasse and Weiss-
man 1997).
Dynamic assembly of transcription factors binding
to FIRE during macrophage differentiation
Although the mouse and human c-fms proximal promot-
ers have been studied extensively, FIRE was described
only recently (Himes et al. 2001). The in vivo and in vitro
analyses herein support the view that FIRE is a crucial
determinant of transcriptional activity at the c-fms locus
during macrophage lineage commitment. In transgenic
mice, the 3.5-kb c-fms exon 2 promoter and downstream
intron containing FIRE are sufficient to direct repro-
ducible and lineage restricted expression of an EGFP
reporter gene. Deletion of the 300-bp FIRE sequence
completely abolished EGFP expression in both stably-
transfected macrophages and transgenic mice (Himes
et al. 2001; R.T. Sasmono, D. Oceandy, J.W. Pollard,
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Figure 7. Developmental change of transcription factor assembly on the FIRE. To quantify the individual bands accurately, LM–PCR
products were labeled with IRD700 and analyzed by use of a LICOR sequencer. Band intensities were quantified and normalized as
described in Fig. 5B. (A) Guanine residues between +2849 and +2862 containing FBF and C/EBP binding sites (upper strand). (B) Guanine
residues between nucleotide positions +2775 and +2791 including two PU.1 binding sites (lower strand). (C) Guanine residues between
+2717 and +2730 (B) including a cluster of binding sites, ets, SP1/3, and AML-1 (lower strand).
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W. Tong, P. Low, R. Thomas, P. Pauli, M.C. Ostrouski,
S.R. Himes, and D.A. Hume, in prep.). The FIRE region
binds a complex set of proteins previously shown to be
important for gene regulation in macrophages, such as
PU.1 C/EBP family, ets-factors, Sp1, and AML1 (Tenen
et al. 1997). Both the promoter and FIRE were bound by
PU.1 in vivo thus confirming the important role of this
transcription factor in the regulation of c-fms expression
in myeloid precursors of adult mice (DeKoter et al. 1998).
During development, other members of the Ets family
may also bind these sites, as the function of PU.1 in
c-fms transcription is at least partly redundant (Ross et
al. 1998; Lichanska et al. 1999; Luchin et al. 2001). Fur-
thermore, we have identified multiple AML/CBF bind-
ing elements in the enhancer region of the mouse c-fms
gene. AML-1 has been strongly implicated in transcrip-
tional regulation in myeloid cells, in line with its clear
role as a target for translocations in human myeloid leu-
kaemias (for review, see Speck 2001). The human c-fms
promoter contains a high affinity AML-1 binding site
that regulates transcription (Zhang et al. 1994; Rhoades
et al. 1996) but neither this sequence, nor an adjacent
C/EBP site, is conserved in the mouse gene. The mouse
enhancer sequence contains two functional binding sites
for AML-1, only one of which, the upstream element, is
completely conserved in the human sequence. Prelimi-
nary experiments with macrophage cell lines carrying
stably transfected FIRE-bearing reporter gene constructs
suggest that AML1/CBF can indeed trans-activate this
element; however, the interpretation of these experi-
ments in complicated by the fact that bacterial DNA
alters macrophage physiology (Sester et al. 1999). This
and because the function of FIRE is dependent on chro-
matin context, functional evaluation of the putative
AML1 site, and other individual FIRE cis-acting ele-
ments, will require the introduction of mutations in the
mouse germ line. The novel myeloid-expressed factor
FBF-1, which binds an element identified through the in
vivo footprinting experiments, is another major focus of
further study.
Our studies clearly indicate that in contrast to the pro-
moter, the extent of transcription factor occupancy at
FIRE increased with increased c-fms transcription during
macrophage differentiation. Within the temporal resolu-
tion of our differentiation system, sequential assembly
of transcription factors could not be detected, suggesting
that the factors on FIRE are organized synchronously
into an enhanceosome (Merika and Thanos 2001). We
infer that transcription factor assembly on FIRE is prob-
ably cooperative, similar to what has been observed with
the T-cell receptor  enhancer (Hernandez-Munain et al.
1998) or the IL-2 promoter/enhancer (Garrity et al. 1994).
Such cooperativity will need to be considered in inter-
preting any effects of individual mutations of the con-
served elements of FIRE.
At the final stages of our macrophage differentiation
culture the composition of the transcription factor com-
plex binding to FIRE enhancer changed. A number of
factor complexes were disassembled, whereas others re-
mained. The most likely reason for this is that c-fms
gene expression is modulated by CSF-1 itself (Yue et al.
1993). As CSF-1 is a vital component of our differentia-
tion culture medium, it is likely that at early stages of
differentiation when no or little CSF-1 receptor is ex-
pressed, precursors rely mostly on IL-3 for proliferation
(Bartelmez et al. 1989; Breen et al. 1990). As the cells
differentiate and express higher levels of CSF-1 receptor,
their growth becomes dependent on the action of CSF-1.
This, in turn, will initiate down-regulation of c-fms tran-
scription. However, prolonged CSF-1 treatment had no
effect on the overall accessibility of chromatin at FIRE.
Similar to the promoter, also extended regions of FIRE
surrounding chromatin stayed accessible to restriction
enzyme digestion in mature, bone marrow-derived mac-
rophages.
Alterations of chromatin fine structure on the c-fms
promoter and transcription factor composition
on FIRE after LPS treatment
Our results indicate that after LPS treatment, the tran-
scription factor occupancy at both the promoter and
FIRE was reduced, and the respective transcription factor
complexes were disassembled. At the promoter, we ob-
served no change in transcription factor composition. All
in vivo G(N7) contacts became weaker, indicating a co-
ordinate destabilization of the promoter complex. How-
ever, LPS treatment was accompanied by distinct chro-
matin fine structure alterations. Our photofootprinting
data show clearly that chromatin structure at the c-fms
promoter does not entirely revert to the pattern seen in
c-fms nonexpressing cells, but rather adopts a new con-
formation, which is particularly apparent around the
transcription start sites. This result is consistent with
our DHS mapping experiments in murine macrophage
cell lines that showed no difference in DNAseI accessi-
bility with or without LPS treatment (Himes et al. 2001).
LPS treatment has been shown to have an effect not only
on c-fms transcription (Gusella et al. 1990), but also af-
fects mRNA elongation downstream of the ATG (Yue et
al. 1993). The chromatin fine structure alterations may
therefore reflect the presence of stalled RNA polymerase
molecules downstream of the transcription start sites.
This would lead to topological changes in DNA struc-
ture that could be picked up by photofootprinting.
mRNA levels of some transcription factors involved in
c-fms regulation were apparently down-modulated after
LPS treatment of macrophages (PU.1, C/EBPs, AML-1;
Fig. 4), which in theory could account for the reduction
of transcription factor occupancy at the promoter and at
FIRE. However, binding to the distal SP1/ets/AML1 clus-
ter at + 2718 bp and the PU.1 (1) site was not reduced
after LPS treatment of day 7macrophages and Sp1/AML1
activity was high in mature macrophage cells (Fig. 8).
One reason for this behavior may be that besides its ac-
tivity as an enhancer that is required for c-fms promoter
activation, FIRE may have a second role as an LPS-in-
ducible antisense promoter (Himes et al. 2001; R. Himes
and D.A. Hume, unpubl.). This would explain the find-
ing that intronic sequences including FIRE are not only
Factor assembly on c-fms gene during myelopoiesis
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required for c-fms activation, but also for the block in
mRNA elongation after LPS treatment (Yue et al. 1993).
In this respect it may be relevant that FIRE contains
several overlapping binding sites for different constitu-
tive and LPS-inducible proteins. For example, Sp1 has
been shown to be LPS inducible (Brightbill et al. 2000; R.
Himes and D.A. Hume, unpubl.) and could maintain
binding in this particular context. Because LPS also
causes posttranscriptional modifications in several of
the factors that bind the FIRE sequence, notably PU.1
(Lodie et al. 1997), it is possible that functional changes
in FIRE occur without changes in binding site occu-
pancy.
Taken together, our experiments provide a first
glimpse into the dynamics of transcription factor com-
plex formation and transcription regulation during cell
differentiation in hematopoietic cells of higher eukary-
otes. Future experiments will employ the techniques we
have developed to gain further insights into the molecu-
lar details of differentiation decisions at the level of chro-
matin structure and expression of myeloid specific
genes.
Materials and methods
Cell purification, tissue culture, and FACS analysis
Bone marrow cells were stained with CD4, CD8, CD11b, CD19,
Gr1, F4/80, Ter119 monoclonal antibodies (mABs), and fol-
lowed by depletion of lineage positive cells by magnetic cell
spearation as described previously (Geiger et al. 1998). The lin-
eage-depleted fraction was stained with anti rat IgG-FITC
(Pharmingen), FITC conjugated anti ER-MP20, PE conjugated
anti c-kit and biotinylated anti ER-MP12 mABs, followed by
streptavidin-PECy5. Cell sorting was performed on a FACS Van-
tage cell sorter (Becton Dickinson). C-kithigh/ER-MP12high/ER-
MP20− cells were cultured in macrophage differentiation me-
dium, which consisted of Iscove’s modified DMEM, 10% FCS,
10% L-cell conditioned medium as a source for CSF-1, 5% IL-3
conditioned medium and 100U/mL recombinant mIL-1 (a gift
from the Genetics Institute). Medium conditioned by X63 Ag8–
653 myeloma cells carrying an expression vector for IL-3 was
used at 5% as a source for IL-3 (Karasuyama andMelchers 1988).
Expression of cell surface antigens was detected by staining
with PE-anti c-kit, FITC-anti ERMP-20, biotinylated anti-
ERMP12, followed by streptavidin-PECy5 and FITC conjugated
anti-CSF-1 receptor mAb, AFS98 (Sudo et al. 1995; a gift from S.
Nishikawa), followed by flow cytometoric analysis performed
on an Epics flow cytometer (Beckman Coulter). Morphological
analysis was performed by May-Grünwald Giemsa staining.
Colony assay
One thousand cells from sorted fraction (C-kithigh/ER-MP12high
and C-kithigh/ER-MP12−) was plated in 1 mL of a murine CFU-
mix assay medium, Methocult M3434, (Stem Cell Technolo-
gies) into 30 mm petri dishes (Sterilin) and cultured in a mois-
ture chamber under 5% CO2 at 37°C. Colonies are counted at
day 8 for BFU-E and myeloid colonies. At day 8, individual
colonies were picked up and subjected to May-Grünwald
Giemsa staining.
Restriction enzyme accessibility assay
Restriction enzyme accessibility assays were performed as de-
scribed previously (Kontaraki et al. 2000). Embryonic fibroblasts
and bone marrow derived macrophages cultured in 6 cm tissue
culture dishes were permeabilized, digested with 100 U of XbaI,
HinfI, PvuII, SspI, XmnI, BanII, HindIII, and EcoRI in the cor-
responding reaction buffer for 1 h at 37°C. After restriction en-
zyme digestion, genomic DNA was purified, digested with
BamHI or PstI to look at the promoter region and second intron,
respectively, and analyzed by Southern blotting by using a PvuI-
Figure 8. Analysis of DNA–protein interactions in vitro. Protein binding assays were performed with nuclear extracts (NE) from
MOP31C B cells (B) or bone marrow-derived macrophages (M). (A) Protein binding to the consensus Sp1 element in the FIRE enhancer.
The Sp1 protein/DNA complex and supershifted complex with Sp1 specific antibody (Sp1SS) are marked. (B) Protein binding to a novel
DNA element, within the FIRE enhancer, showing myeloid specificity (FBF1). Assays were performed with the nuclear extracts
described in A. (Lower panel) Control for the different extracts using an oct consensus oligo. The upper, stronger band is generated by
oct1, the lower band by oct2. (C) Protein binding assays were performed on one of the consensus AML-1 sites within the FIRE
enhancer. Assays were performed with the nuclear extracts described in A. (D) Distinct protein–DNA complexes forming on the FIRE
AML element (FAML) were compared to those forming on the previously characterized MMLV LTR binding site (VAML). Nuclear
extracts from BMM were used in the assays (M). The ability of each element to cross-compete for protein binding was also assessed
by addition of excess unlabeled oligonucleotide (comp.). The AML/CBF related protein binding is marked.
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I–BamHI fragment as a probe as described previously (Himes et
al. 2001).
RT–PCR
Total RNA was extracted from cells by using TRIZOL reagent
(Invitrogen) according to the manufacturer’s instructions. First-
strand cDNA synthesis and PCR amplification were carried out
as described previously (Tagoh et al. 1995). PCR was performed
in 30 µL of reaction solution containing 1.5 U of rTaq polymer-
ase (Promega), 0.2 mM of dNTPs, and 1 µM of primers. PCR
products were resolved on agarose gels containing ethidium bro-
mide and stained bands were quantified using a PhosphorImager
(Bio-Rad). The linear range of amplification was determined and
signals were normalized to the GAPDH signal. Primer se-
quences were as follows (Clarke et al. 2000): GAPDH upper; 5-
GGTCATCATCTCCGCCCCTTCTGC, GAPDH lower; 5-
GAGTGGGAGTTGCTGTTGAAGTCG, c-fms upper; 5-GC
GATGTGTGAGCAATGGCAGT, c-fms lower; 5-AGACC
GTTTTGCGTAAGACCTG, m-lys upper; 5-ACCCAGCCTC
CAGTCACCAT, m-lys lower; 5-CAGTGCTTTGGTCTCCA
CGG, PU.1 upper; 5-TTTGCCTCCCACCAGGACTC, PU.1
lower; 5-ACTAAGCCAGGCTGACCCTC, C/EBP upper; 5-
AGTGTGCACGTCTATGCTA, C/EBP lower; 5-GTGTGTA
TGAACTGGCTGGA, C/EBP upper; 5-CGGGACTTGATGC
AATCCG, C/EBP lower; 5-CAACCCCGCAGGAACATCT
TGATA-1 upper; 5-GGAGGAATGCCAGCGGAGGAT, GATA-1
lower; 5-TGTAGGCGATCCCAGCAGAGG, GATA-2 upper;
5-ACGCCCACGCCTATCCAC. GATA-2 lower; 5-CGAGC
TGCAGCCCAGTTAGAA, AML-1 upper; CGGAGCGGTAG
AGGCAAGA 5-, AML-1 lower; 5-GAGATGGACGGCAGA
GTAGGG, iNOS upper; 5-GAGGAGAGAGATCCGATTTA
GAGTCTTGG, iNOS lower; 5-CAGTCTCCATTCCCAAAT
GTGCTTGT CAC.
In vivo genomic footprinting assays
DMS treatment and UV irradiation of cells and naked DNA,
preparation of genomic DNA, LM-PCR, and TD-PCR were per-
formed as described previously (Kontaraki et al. 2000) with the
following modifications. Lambda DNA was used as a carrier
during the genomic DNA preparation procedure. PCR amplifi-
cation for LM- and TD-PCR was carried out using Pfu Turbo
DNA polymerase (Stratagene) in buffer containing 1.4 M Beta-
ine and 5% DMSO. PCR amplified products were labeled by
primer extension using 32P- or IRD (LICOR) 5-labeled primers.
Quantification of band intensity was carried out on digitized
data from a LICOR DNA sequencer using the ImagIR analysis
program as described previously (Kontaraki et al. 2000; Chen et
al. 2001). The primer sets for the promoter region were, Prom01
(+36–+56); 5-CCCTTACCATGCCAAACTGTG, Prom02 (+21–
+41); 5-ACTGTGGCCAGCAGCAGGACC, Prom03D (+4–+24);
5-GACCAGAGGAGGCCCCAACTC. Those for FIRE upper
strand were, GB04 (+2959–+2979); GAGGTACCCAGTCTGC
TGAGG, GB05 (+2937–+2957); ACCCAGTCTGCCCTCGC
TTCT, GB06 (+2927–+2947); CCCTCGCTTCTCTGAGCC
TGC . Primers for FIRE lower strand were, GB01 (+2586–+2606);
TTGCCAAGAGTCCCTCAGTGT, GB02 (+2597–+2617); CCC
TCAGTGTGTGAGAAGGAC.
EMSA
BMM were prepared from ∼2 − 4 × 107 bone marrow cells
treated in culture with 1 × 104 units/mL of rhCSF-1 (Cetus Cor-
poration) for 7 d. Nuclear extracts from BMM, and the MOP31C
B-cell line were prepared according to a modified procedure
from Schreiber et al. (1989), where 0.2% NP40 was used in the
cell lysis buffer (Schreiber et al. 1989). Protein binding reactions
were performed in 20 mMHepes, 50 mMNaCl, 2 mMDTT, 0.5
mM EDTA, and 15% glycerol. Nuclear extracts were precleared
for nonspecific protein binding by incubation of 1.5 µg of pro-
tein extract with 0.4 µg of poly dI-dC:poly dI-dC and 0.2 µg of
highly fragmented Herring sperm DNA on ice for 5 min at 4°C
and at room temperature for 5 min in reaction buffer, before
addition of probe. For oligonucleotide competitions, a 200-fold
excess of unlabeled competitor was added. 1.5 µL of Sp1-specific
polyclonal antibody (Santa Cruz Biochemical) was added for su-
pershift assay and this reaction was preincubated on ice for 15
min. Double-stranded oligonucleotide probes were end labeled
with 32P by T4 poylnucleotide kinase reaction and purified by
band isolation on polyacrylamide gels. Approximately 0.1 ng of
probe was added to each reaction and incubated for 20 min at
room temperature. Protein binding assays were run on 5% poly-
acrylamide containing 0.5× TBE buffer (0.5 mM Tri, 42 mM
boric acid, 1 mM EDTA). Oligonucleotides used for EMSA con-
tained the following sequences: FIRE Sp1, TGTGTGGGCG
GAAACA; FIRE NoMS, AGACCTGACAGGGGGTTTGAGT
TC; FIRE AML, TCGTTGCCTGTGTGGTGTCAGC; MMLV
LTR AML, GGATATCTGTGGTAAGCA; and oct1, AGTATG
CAAAGCAT.
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